236 related articles for article (PubMed ID: 19997836)
1. [How to use PSA in 2009].
Ponholzer A; Stoiber F; Loidl W; Rauchenwald M; Schramek P; Madersbacher S
Wien Med Wochenschr; 2009; 159(21-22):515-20. PubMed ID: 19997836
[TBL] [Abstract][Full Text] [Related]
2. [PSA 2010--the beginning of a new era in early detection of prostate cancer].
Börgermann C; Sieverding M; Fornara P; Graefen M; Hammerer P; Semjonow A; Schröder F; Rübben H
Urologe A; 2006 Sep; 45 Suppl 4():127-33. PubMed ID: 16941115
[No Abstract] [Full Text] [Related]
3. [Advantages and risks of the use of prostate-specific antigen (PSA) in the health-care area No. 4 of Gijon (Asturias)].
Cepeda Piorno J; Rivas del Fresno M; Fuente Martín E; González García E; Muruamendiaraz Fernández V; Fernández Rodríguez E
Arch Esp Urol; 2005 Jun; 58(5):403-11. PubMed ID: 16078781
[TBL] [Abstract][Full Text] [Related]
4. [Serum markers for early detection and staging of prostate cancer. Status report on current and future markers].
Haese A; Graefen M; Palisaar J; Huland E; Huland H
Urologe A; 2003 Sep; 42(9):1172-87. PubMed ID: 14504750
[TBL] [Abstract][Full Text] [Related]
5. Incidental carcinoma of the prostate.
van Andel G; Vleeming R; Kurth K; de Reijke TM
Semin Surg Oncol; 1995; 11(1):36-45. PubMed ID: 7538693
[TBL] [Abstract][Full Text] [Related]
6. [Rates of prostate-specific antigen testing for early detection of prostate cancer: a first comparison of German results with current international data].
Lebentrau S; May M; Maurer O; Schostak M; Lehsnau M; Ecke T; Al-Dumaini S; Hallmann S; Ahmed AM; Braun V; Haferkamp A; Bauer RM; Stief CG; Baumunk D; Hoschke B; Braun HP; Schäfer C; Hipp M; Maurer J; Braun KP; Wolff I; Brookman-May S; Gilfrich C
Urologe A; 2014 May; 53(5):715-24. PubMed ID: 24700162
[TBL] [Abstract][Full Text] [Related]
7. [Improved discrimination between prostatic carcinoma and benign prostatic hyperplasia by determination of free prostate-specific antigen percentage].
Wolff JM; Borchers H; Boeckmann W; Habib FK; Jakse G
Urologe A; 1997 May; 36(3):255-8. PubMed ID: 9265347
[TBL] [Abstract][Full Text] [Related]
8. [PSA screening--medically useful or superfluous?].
Glatz U
Dtsch Med Wochenschr; 2010 Jan; 135(4):p3. PubMed ID: 20101552
[No Abstract] [Full Text] [Related]
9. [Mass screening for prostate cancer at Ikeda City in Osaka Prefecture--results of screening with PSA alone between 2003 and 2007].
Inoue H; Kinouchi T; Kinoshita T; Kobayashi M; Ued T; Takada T; Hara T; Yamaguchi S; Kajimoto M; Kitamura K
Nihon Hinyokika Gakkai Zasshi; 2010 Jul; 101(5):671-5. PubMed ID: 20715498
[TBL] [Abstract][Full Text] [Related]
10. [The significance of early detection for prostate cancer in mass screening].
Kato M; Tammbo M; Yoshimatsu T; Ohta M; Kinjyo M; Noda H; Watanabe K; Miyata A; Murata A; Miura I; Yoneda T; Yoshii M; Okegawa T; Kojima M; Sayama T; Nutahara K; Higashihara E
Nihon Hinyokika Gakkai Zasshi; 2001 Jan; 92(1):23-9. PubMed ID: 11235139
[TBL] [Abstract][Full Text] [Related]
11. [PSA-based early detection of prostate cancer].
Luboldt H; Rübben H
Urologe A; 2000 Jan; 39(1):22-6. PubMed ID: 10663192
[TBL] [Abstract][Full Text] [Related]
12. [Significance of the PSA-concentration for the detection of prostate cancer].
Stachon A
Pathologe; 2005 Nov; 26(6):469-72. PubMed ID: 16195861
[TBL] [Abstract][Full Text] [Related]
13. [Additional aids in detection of prostate carcinomas? PSA-prostatic volume quotient, PSA-doubling time, age-dependent PSA reference values and PSA in urine].
Pannek J; Brands FH
Urologe A; 2000 Jul; 39(4):324-9. PubMed ID: 10957773
[TBL] [Abstract][Full Text] [Related]
14. [Status of PSA determination for early detection of prostate carcinoma].
Hammerer P; Huland H
Versicherungsmedizin; 1995 Jun; 47(3):83-6. PubMed ID: 7541925
[TBL] [Abstract][Full Text] [Related]
15. [Detection of prostate cancer. German guideline recommends opportunist screening].
Arnheim K
MMW Fortschr Med; 2010 Sep; 152(39):12-3. PubMed ID: 21058430
[No Abstract] [Full Text] [Related]
16. [New challenges and earlier approved methods in the laboratory diagnosis of prostate cancer].
Kovács GL
Magy Onkol; 2014 Dec; 58(4):301-9. PubMed ID: 25517448
[TBL] [Abstract][Full Text] [Related]
17. Comparison of prostate specific antigen with prostate specific antigen density for 3 clinical applications.
Shinohara K; Wolf JS; Narayan P; Carroll PR
J Urol; 1994 Jul; 152(1):120-3. PubMed ID: 7515447
[TBL] [Abstract][Full Text] [Related]
18. Twenty-year Risk of Prostate Cancer Death by Midlife Prostate-specific Antigen and a Panel of Four Kallikrein Markers in a Large Population-based Cohort of Healthy Men.
Sjoberg DD; Vickers AJ; Assel M; Dahlin A; Poon BY; Ulmert D; Lilja H
Eur Urol; 2018 Jun; 73(6):941-948. PubMed ID: 29519548
[TBL] [Abstract][Full Text] [Related]
19. Natural history of PSA increase with and without prostate cancer.
Ito K; Yamamoto T; Ohi M; Takechi H; Kurokawa K; Suzuki K; Yamanaka H
Urology; 2003 Jul; 62(1):64-9. PubMed ID: 12837424
[TBL] [Abstract][Full Text] [Related]
20. [The role of PSA in diagnosis of prostate cancer and its recurrence].
Vergho DC; Heine K; Wolff JM
Pathologe; 2005 Nov; 26(6):473-8. PubMed ID: 16215709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
